Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1026.28% is 127% below its 3-year average of -451.61%, near the low end of its 3-year range (-1196.78%–0.00%).
1.11% above its 12-month average of -1037.84%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1196.78%.
OPERATING MARGIN
-1026.28%
OPERATING MARGIN AVG TTM
-1037.84%
OPERATING MARGIN AVG 3Y
-486.35%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+1.11%
CURRENT VS 3Y AVG
-111.01%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BioAge Labs Inc.
Market Cap
$239.45M
Operating Margin
-1026.28%
TTM Avg
-1037.84%
3Y Avg
-486.35%
5Y Avg
N/A
Market Cap
$239.89M
Operating Margin
0.56%
TTM Avg
-0.74%
3Y Avg
-7.55%
5Y Avg
-6.74%
Market Cap
$236.56M
Operating Margin
-31.37%
TTM Avg
-39.87%
3Y Avg
-74.09%
5Y Avg
-70.30%
Market Cap
$244.25M
Operating Margin
9.95%
TTM Avg
-10.78%
3Y Avg
-18.24%
5Y Avg
-54.36%
Market Cap
$245.65M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$247.23M
Operating Margin
-103.99%
TTM Avg
-400.39%
3Y Avg
-200.20%
5Y Avg
-133.47%
Market Cap
$247.45M
Operating Margin
-164525.50%
TTM Avg
-98218.45%
3Y Avg
-66780.63%
5Y Avg
-44520.42%
Market Cap
$248.21M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$228.41M
Operating Margin
28.94%
TTM Avg
-2955.01%
3Y Avg
-29613.43%
5Y Avg
-19789.03%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioAge Labs Inc. (BIOA) | $239.45M | -1026.28% | -1037.84% | -486.35% | N/A |
| High Tide Inc. (HITI)vs › | $239.89M | 0.56% | -0.74% | -7.55% | -6.74% |
| Biodesix, Inc. (BDSX)vs › | $236.56M | -31.37% | -39.87% | -74.09% | -70.30% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | 9.95% | -10.78% | -18.24% | -54.36% |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | 0.00% | 0.00% | 0.00% | 0.00% |
| Invivyd, Inc. (IVVD)vs › | $247.23M | -103.99% | -400.39% | -200.20% | -133.47% |
| InflaRx N.V. (IFRX)vs › | $247.45M | -164525.50% | -98218.45% | -66780.63% | -44520.42% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Keros Therapeutics, Inc. (KROS)vs › | $228.41M | 28.94% | -2955.01% | -29613.43% | -19789.03% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $251.64M | -1488.31% | -4815.32% | -6115.40% | -4078.06% |
Gross Margin
99.4%
Operating Margin
-1026.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1196.78% |
| 2026-03-31 | -915.40% |
| 2025-12-31 | -923.42% |
| 2025-09-30 | -1126.58% |
| 2025-06-30 | -1026.99% |
| 2025-03-31 | -1133.43% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
